Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bright Minds Biosciences Inc (DRUG)

Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 626,756
  • Shares Outstanding, K 7,786
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,060 K
  • EBIT $ -6 M
  • EBITDA $ -6 M
  • 60-Month Beta -6.22
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 13.63

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate -0.69
  • Number of Estimates 2
  • High Estimate -0.51
  • Low Estimate -0.88
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -475.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.13 +54.42%
on 11/06/25
82.00 -1.83%
on 12/05/25
+28.33 (+54.30%)
since 11/05/25
3-Month
39.70 +102.79%
on 09/09/25
82.00 -1.83%
on 12/05/25
+38.26 (+90.58%)
since 09/05/25
52-Week
23.17 +247.36%
on 06/27/25
82.00 -1.83%
on 12/05/25
+41.35 (+105.62%)
since 12/05/24

Most Recent Stories

More News
Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

-- Tania Markovic MBBS PhD FRACP; Jennifer L. Miller, MD; Elizabeth Roof, H.S.P., M.A.; and Theresa V. Strong, PhD; distinguished global experts in PWS, will support the Company’s PWS program, which...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

-- Company will host a webcast at 10am ET on November 6, 2025, to discuss its Phase 2a study to assess efficacy, safety and tolerability of BMB-101 (NOVA Study) for the treatment of patients with Prader-Willi...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences to Present at Upcoming Conferences

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
BTIG Remains a Buy on Bright Minds Biosciences (DRUG)

BTIG analyst Thomas Shrader maintained a Buy rating on Bright Minds Biosciences yesterday and set a price target of $72.00. The company’s shares closed yesterday at C$80.95.Elevate Your Investing Strategy:...

DRUG : 80.50 (+11.03%)
BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING

/CNW/ - Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company") announces that it has entered into an equity distribution...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING

VANCOUVER, BC , Sept. 4, 2025 /CNW/ - Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (" Bright Minds " or the " Company ") announces that it has entered into an equity...

DRUG : 80.50 (+11.03%)
Bright Minds Biosciences Announces BMB‑201 Outperforms Sumatriptan in Validated Preclinical Vascular Headache Model

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG) today announced compelling preclinical results for its investigational compound BMB‑201, in a validated isosorbide...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences to Present at Upcoming Conferences

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)

Business Summary

Bright Minds Biosciences is a biotechnology company. It focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain. Bright Minds Biosciences is based in VANCOUVER, British Columbia.

See More

Key Turning Points

3rd Resistance Point 94.15
2nd Resistance Point 88.07
1st Resistance Point 84.29
Last Price 80.50
1st Support Level 74.43
2nd Support Level 68.35
3rd Support Level 64.57

See More

52-Week High 82.00
Last Price 80.50
Fibonacci 61.8% 59.53
Fibonacci 50% 52.59
Fibonacci 38.2% 45.65
52-Week Low 23.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar